Wellgistics Health reported Q1 2026 results showing sequential growth in pharmacy revenue and announced partnerships with Kare Pharmtech and Tollo Health to expand direct-to-patient capabilities, while terminating non-binding LOIs with Neuritek and WellCare. The company is advancing integration of its PharmacyChain and EinsteinRx technologies and preparing for an August 2026 product launch targeting 200,000+ patient lives.